AtonRa Partners
- SEC CIK
- 0001846445
- Latest filing
- Feb 5, 2024
MDGL holding history
Madrigal Pharmaceuticals, Inc. in every 13F filed by AtonRa Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDGL overviewAll 13F holders of MDGLFull Q4 2023 holdings
- Shares (Q4 2023)
- 3,433
- Value
- $794.3K
- % of portfolio
- 1.6%
- Quarters held
- 7
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 3,433 | $794.3K | 1.6% | −424−11.0% | Reduced | Holders |
| Q3 2023 | 3,857 | $563.3K | 1.2% | −901−18.9% | Reduced | Holders |
| Q2 2023 | 4,758 | $1.10M | 1.7% | −550−10.4% | Reduced | Holders |
| Q1 2023 | 5,308 | $1.29M | 1.9% | −398−7.0% | Reduced | Holders |
| Q4 2022 | 5,706 | $1.66M | 2.1% | −1,543−21.3% | Reduced | Holders |
| Q3 2022 | 7,249 | $471.0K | 0.5% | −35−0.5% | Reduced | Holders |
| Q2 2022 | 7,284 | $521.0K | 0.5% | +7,284 | New | Holders |